Methimazole

Product manufactured by Par Pharmaceutical

Application Nr Approved Date Route Status External Links
ANDA040350 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Methimazole Tablets Are Indicated: • In Patients With Graves’ Disease With Hyperthyroidism Or Toxic Multinodular Goiter For Whom Surgery Or Radioactive Iodine Therapy Is Not An Appropriate Treatment Option. • To Ameliorate Symptoms Of Hyperthyroidism In Preparation For Thyroidectomy Or Radioactive Iodine Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Methimazole METHIMAZOLE ZINC1187543

Comments